These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24104554)

  • 1. Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy.
    Song X; Sturgis EM; Huang Z; Li X; Li C; Wei Q; Li G
    Carcinogenesis; 2014 Jan; 35(1):62-8. PubMed ID: 24104554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx.
    Jin L; Sturgis EM; Cao X; Song X; Salahuddin T; Wei Q; Li G
    FASEB J; 2013 Jun; 27(6):2496-503. PubMed ID: 23430974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.
    Zhang Y; Sturgis EM; Wei P; Liu H; Wang Z; Ma Y; Liu C; Gu KJ; Wei Q; Li G
    Mol Carcinog; 2019 Dec; 58(12):2276-2285. PubMed ID: 31513313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Zhu L; Sturgis EM; Zhang H; Lu Z; Tao Y; Wei Q; Li G
    Int J Cancer; 2017 Oct; 141(7):1355-1364. PubMed ID: 28646528
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Tao Y; Sturgis EM; Huang Z; Wang Y; Wei P; Wang JR; Wei Q; Li G
    Clin Cancer Res; 2018 May; 24(9):2225-2233. PubMed ID: 29463556
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx.
    Guan X; Sturgis EM; Song X; Liu Z; El-Naggar AK; Wei Q; Li G
    Cancer Lett; 2013 Apr; 330(2):233-40. PubMed ID: 23219900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.
    Zhang Y; Sturgis EM; Li Y; Wei Q; Huang Z; Li G
    Sci Rep; 2017 Jan; 7():39765. PubMed ID: 28045062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.
    Li Y; Sturgis EM; Zhu L; Cao X; Wei Q; Zhang H; Li G
    Mol Carcinog; 2017 Apr; 56(4):1335-1343. PubMed ID: 27864908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.
    Zhang Y; Sturgis EM; Sun Y; Sun C; Wei Q; Huang Z; Li G
    Eur J Cancer; 2015 Jul; 51(11):1415-23. PubMed ID: 25981582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
    Zhang Y; Sturgis EM; Zafereo ME; Wei Q; Li G
    Cancer; 2011 Mar; 117(6):1227-35. PubMed ID: 21381012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Lu Z; Sturgis EM; Zhu L; Zhang H; Tao Y; Wei P; Wei Q; Li G
    Mol Carcinog; 2018 Mar; 57(3):361-369. PubMed ID: 29073727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer.
    Guan X; Sturgis EM; Lei D; Liu Z; Dahlstrom KR; Wei Q; Li G
    Clin Cancer Res; 2010 Mar; 16(5):1416-22. PubMed ID: 20179236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.
    Zhang C; Sturgis EM; Zheng H; Song X; Wei P; Jin L; Chao L; Wei Q; Li G
    Int J Cancer; 2014 Apr; 134(8):1907-15. PubMed ID: 24122460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy.
    Sun P; Wei P; Liu H; Wu J; Gross ND; Sikora AG; Wei Q; Shete S; Zafereo ME; Liu J; Li G
    EBioMedicine; 2023 Aug; 94():104722. PubMed ID: 37487414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic variants with tumor HPV16 status and survival in squamous cell carcinoma of the oropharynx.
    Feng Y; Li Y; Zhang Y; Zheng H; Li G
    Oral Oncol; 2016 May; 56():78-83. PubMed ID: 27086490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
    Zhang F; Sturgis EM; Sun Y; Zhang Y; Wei Q; Zhang C; Zheng H; Li G
    Int J Cancer; 2015 Nov; 137(10):2454-61. PubMed ID: 25976983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
    Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
    Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.
    Chen X; Sturgis EM; Wang C; Cao X; Li Y; Wei Q; Li G
    Oncotarget; 2016 Jun; 7(23):35015-25. PubMed ID: 27145460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
    Wang C; Sturgis EM; Chen X; Wei Q; Li G
    Oncotarget; 2016 Jun; 7(23):34472-9. PubMed ID: 27121322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.